From professional translators, enterprises, web pages and freely available translation repositories.
- incontinence.
- irritation may occur.
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
dogs hormone - dependent urinary incontinence (qg03ca04)
dogs hormone-dependent urinary incontinence (qg03ca04)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
treatment of ileal pouch anal anastomosis (ipaa) related faecal incontinence
· treatment of ileal pouch anal anastomosis (ipaa) related faecal incontinence
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence
note for guidance on clinical investigation of medicinal products for treatment of nociceptive pain
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women
note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
utilizando a base lilacs e os descritores urinary and incontinence and race, três artigos foram encontrados.
using the lilacs database and the descriptors urinary and incontinence and race, three articles were found.
Last Update: 2020-08-01
Usage Frequency: 1
Quality:
concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women
concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
os instrumentos utilizados foram um questionário de avaliação clínica e um de qualidade de vida denominado international consultation on incontinence questionnnaire - short form iciq-sf.
the instruments used were a questionnaire for clinical assessment and a questionnaire of quality of life iciq-sf.
Last Update: 2020-08-01
Usage Frequency: 1
Quality:
dado o impacto que a iu pode ter sobre a qualidade de vida, o international consultation on incontinence questionnaire-short form iciq-sf tem sido utilizado para medir essa relação.
given the impact that ui has on quality of life, the international consultation on incontinence questionnaire-short form iciq-sf has been used to measure this relationship.
Last Update: 2020-08-01
Usage Frequency: 1
Quality:
foram criados o questionário para o Índice de continência fecal icf, baseado no clinical evaluation of faecal continence holschneider criteria, e o questionário para avaliar a qualidade de vida relativa à continência fecal em crianças e adolescentes qqvcfca, baseado no fecal incontinence quality of life fiql.
the questionnaire for the fecal incontinence index fii, based on the clinical evaluation of fecal continence holschneider criteria and the questionnaire for the assessment of quality of life related to fecal continence in children and adolescents qqvcfca, based on the fecal incontinence quality of life fiql were created.
Last Update: 2020-08-01
Usage Frequency: 1
Quality:
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow- acting anti- rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti- fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.